Panel of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutations-Reference-Cited by-同舟云学术

Panel of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutations

Published:2005-04-29 Issue:7 Volume:19 Page:731-733
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Johnston Elizabeth,Dupnik Kathryn M,Gonzales Matthew J,Winters Mark A,Rhee Soo-Yon,Imamichi Tomozumi,Shafer Robert W

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference13 articles.

1. Colinearity of reverse transcriptase inhibitor resistance mutations detected by population-based sequencing;Gonzales;J Acquir Immune Defic Syndr,2003

2. Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors;Gonzales;AIDS,2003

3. Distribution of human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns in 4,183 persons undergoing genotypic resistance testing;Rhee;Antimicrob Agents Chemother,2004

4. Protease and reverse transcriptase mutation patterns in HIV type 1 isolates from heavily treated persons: comparison of isolates from Northern California with isolates from other regions;Gonzales;AIDS Res Hum Retroviruses,2003

5. K65R with and without S68: a new resistance profile in vivo detected in most patients failing abacavir, didanosine and stavudine;Roge;Antivir Ther,2003

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of new acetamide derivatives of 5-indole-1,3,4-oxadiazol-2-thiol as inhibitors of HIV-1 Tat-mediated viral transcription;Antimicrobial Agents and Chemotherapy;2024-09-04

2. Optimization of HIV Sequencing Method Using Vela Sentosa Library on Miseq Ilumina Platform;Genes;2024-02-19

3. Discovery of an L‐like Configuration for 3’‐Fluoro‐5’‐norcarbonucleoside Phosphonates as Potent Anti‐HIV Agents;ChemMedChem;2022-09-15

4. Model systems of human immunodef iciency virus (HIV-1) for in vitro eff icacy assessment of candidate vaccines and drugs against HIV-1;Vavilov Journal of Genetics and Breeding;2022-04-05

5. Development of a pseudovirus assay and evaluation to screen natural products for inhibition of HIV-1 subtype C reverse transcriptase;Journal of Ethnopharmacology;2020-08